Actuarial Studies: Estimated impact of MACRA (2015)
Guidance for Estimated Financial Effects of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2)
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 17, 2018
Estimated Financial Effects of the Medicare Access and CHIP Reauthorization Act
of 2015 (H.R. 2)
On March 26, 2015, the House passed the Medicare Access and CHIP Reauthorization Act of
2015 (H.R. 2). This bill includes a provision to replace the Sustainable Growth Rate (SGR)
formula used by Medicare to pay physicians with new systems for establishing annual payment
rate updates for physicians’ services. In addition, it would temporarily extend the Children’s
Health Insurance Program (CHIP) and increase premiums for Part B and Part D of Medicare for
beneficiaries with income above certain levels. H.R. 2 would also make numerous other changes
to Medicare and Medicaid.
This memorandum summarizes the Office of the Actuary’s estimates of the short-range and
long-range financial effects of H.R.2, describes the bill’s major provisions, and discusses the
implications and limitations of the estimates.
The last two sentences of the 3rd full paragraph on page 5 that currently reads:
"Over the 75-year period, the actuarial deficit would be reduced from the current-law estimate of 0.87 percent of taxable payroll to 0.78 percent under H.R. 2. Similarly, the present value of future Part A benefits would decrease by $387 billion-from $20.365 trillion to $19.978 trillion."
Should read as follows:
"Over the 75-year period, the actuarial deficit would be reduced from the current-law estimate of 0.87 percent of taxable payroll to 0.84 percent under H.R. 2. Similarly, the present value of future Part A benefits would decrease by $136 billion-from $20.365 trillion to $20.229 trillion."
See downloads below.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.